fasenra
astrazeneca ab - benralizumab - asthma - drugs for obstructive airway diseases, - fasenra is indicated as an add on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long acting β agonists.
fasenra 30mg1ml solution for injection pre-filled syringes
astrazeneca uk ltd - benralizumab - solution for injection - 30mg/1ml
fasenra
astrazeneca (israel) ltd - benralizumab - solution for injection - benralizumab 30 mg / 1 ml - benralizumab - fasenra is indicated as an add-on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting β-agonists.
fasenra solution for injection 30mgml (pre-filled syringe)
astrazeneca singapore pte ltd - benralizumab - injection, solution - benralizumab 30 mg/ml
fasenra solution for injection 30mgml (autoinjector pen)
astrazeneca singapore pte ltd - benralizumab - injection, solution - benralizumab 30 mg / ml
fasenra solution
astrazeneca canada inc - benralizumab - solution - 30mg - benralizumab 30mg - interleukin antagonists
fasenra pen solution
astrazeneca canada inc - benralizumab - solution - 30mg - benralizumab 30mg - interleukin antagonists
fasenra 30mg/ml sol. for injection solution for injection
astrazeneca ab, sweden - benralizumab - solution for injection - 30 mg/ml
fasenra solution for injection 30 mg/1 ml
مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - benralizumab 30 mg/1 ml - 30 mg/1 ml
fasenra pen solution for injection
astrazeneca ab, sweden - benralizumab - solution for injection - 30 mg/ml,